Switch to
More onapp

How to use scorecard? Learn more

Indoco Remedies Ltd

INDOCO
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,866 cr, stock is ranked 889
Moderate RiskStock is 2.44x as volatile as Nifty
326.150.00 (+0.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,866 cr, stock is ranked 889
Moderate RiskStock is 2.44x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
29.11
PB RatioPB Ratio
2.79
Dividend YieldDiv. Yield
0.48%
Sector PESector PE
41.34
Sector PBSector PB
5.97
Sector Div YldSctr Div Yld
0.61%

Forecast & RatingsDetailed Forecast 

67%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Indoco Remedies Limited is engaged in the manufacture of pharmaceutical products. The Company primarily manufactures and markets Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).

Financial TrendFinancial statements 

20212022202320241.241.541.671.840.090.150.140.10
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Press Release 
Announced OnMay 21, 2024

Indoco Remedies Limited has informed the Exchange regarding a press release dated May 21, 2024, titled "Indoco Remedies receives final ANDA approval from USFDA for Pregabalin capsules". | Download

Indoco Remedies Limited has informed the Exchange regarding a press release dated May 21, 2024, titled "Indoco Remedies receives final ANDA approval from USFDA for Pregabalin capsules". | Download

Outcome of Board Meeting-XBRL 
Announced OnMay 16, 2024

INDOCO REMEDIES LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 16-May-2024 for Dividend | Download

INDOCO REMEDIES LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 16-May-2024 for Dividend | Download

Cash Dividend 
Ex. DateSep 18, 2023

Final • Div/Share: ₹ 2.25

See all events